Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
384.83
362.36
295.71
227.11
183.84
116.12
90.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
384.83
362.36
295.71
227.11
183.84
116.12
90.81
Raw Material Cost
173.81
175.78
167.65
110.40
96.21
60.55
45.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.63
-4.42
-18.24
-4.71
-1.75
-1.77
-0.85
Employee Cost
68.01
55.51
25.89
22.70
15.91
10.88
9.46
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
31.79
23.82
17.78
13.40
10.33
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
69.96
60.89
28.63
21.78
12.99
8.32
8.75
Total Expenditure (Excl Depreciation)
309.15
287.75
235.72
173.99
141.14
91.38
72.90
Operating Profit (PBDIT) excl Other Income
75.68
74.61
59.99
53.12
42.70
24.74
17.91
Other Income
11.18
6.44
1.36
0.75
0.76
0.50
0.41
Operating Profit (PBDIT)
86.86
81.05
61.35
53.87
43.46
25.24
18.32
Interest
15.31
6.99
2.82
2.41
1.90
2.42
2.59
Exceptional Items
0.00
-4.57
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
71.55
69.49
58.53
51.46
41.56
22.82
15.73
Depreciation
17.15
12.51
9.78
10.41
7.25
6.87
3.76
Profit Before Tax
54.39
56.97
48.75
41.06
34.30
15.95
11.97
Tax
12.91
14.55
12.32
10.34
9.47
4.23
2.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.48
42.42
36.44
30.72
24.83
11.72
9.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
41.48
42.42
36.44
30.72
24.83
11.72
9.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.48
42.42
36.44
30.72
24.83
11.72
9.42
Equity Capital
10.14
10.09
9.61
9.61
9.61
9.61
9.61
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
234.63
187.00
147.50
113.27
82.73
59.00
47.50
Earnings per share (EPS)
40.91
42.04
36.11
31.97
25.84
12.2
9.8
Diluted Earnings per share
40.92
42.02
36.1
31.95
25.82
12.2
9.93
Operating Profit Margin (Excl OI)
19.67%
20.59%
20.29%
23.39%
23.23%
21.31%
19.72%
Gross Profit Margin
18.59%
19.18%
19.79%
22.66%
22.61%
19.65%
17.32%
PAT Margin
10.78%
11.71%
12.32%
13.53%
13.51%
10.09%
10.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.20% vs 22.54% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -2.22% vs 16.41% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 1.43% vs 24.37% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 119.03% vs 147.87% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Beta Drugs Ltd With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
384.83
311.10
73.73
23.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
384.83
311.10
73.73
23.70%
Raw Material Cost
173.81
63.95
109.86
171.79%
Purchase of Finished goods
0.00
17.60
-17.60
-100.00%
(Increase) / Decrease In Stocks
-2.63
6.78
-9.41
-138.79%
Employee Cost
68.01
62.42
5.59
8.96%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
69.96
99.31
-29.35
-29.55%
Total Expenditure (Excl Depreciation)
309.15
250.05
59.10
23.64%
Operating Profit (PBDIT) excl Other Income
75.68
61.05
14.63
23.96%
Other Income
11.18
3.92
7.26
185.20%
Operating Profit (PBDIT)
86.86
64.97
21.89
33.69%
Interest
15.31
12.70
2.61
20.55%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
71.55
52.27
19.28
36.89%
Depreciation
17.15
16.80
0.35
2.08%
Profit Before Tax
54.39
35.47
18.92
53.34%
Tax
12.91
10.75
2.16
20.09%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
41.48
24.73
16.75
67.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
41.48
24.73
16.75
67.73%
Share in Profit of Associates
0.00
4.10
-4.10
-100.00%
Minority Interest
0.00
-1.34
1.34
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.48
27.49
13.99
50.89%
Equity Capital
10.14
8.51
1.63
19.15%
Face Value
10.00
10.00
0.00
Reserves
234.63
305.75
-71.12
-23.26%
Earnings per share (EPS)
40.91
32.30
8.61
26.66%
Diluted Earnings per share
40.92
33.89
7.03
20.74%
Operating Profit Margin (Excl OI)
19.67%
19.62%
0.00
0.05%
Gross Profit Margin
18.59%
16.80%
0.00
1.79%
PAT Margin
10.78%
9.27%
0.00
1.51%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 384.83 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.20% vs 22.54% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 41.48 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.22% vs 16.41% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.43% vs 24.37% in Mar 2025
Annual - Interest
Interest 15.31 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 119.03% vs 147.87% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.67%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
